Portfolio company
Cyclomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology firm develops DNA sequencing and AI-powered diagnostic software for clinicians and researchers to detect cancer and classify tumours using liquid biopsies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.
Cambridge Cancer Genomics
This company develops precision oncology software for clinicians to monitor treatment response and detect cancer relapse using genomic data and blood samples.
Flomics
Flomics develops liquid biopsy blood tests and a bioinformatics platform for early cancer detection in clinical and research settings.
Oncoradiomics
This deep-tech firm develops AI-powered image analysis software for pharmaceutical companies and clinicians to improve cancer diagnostics and treatment evaluation through quantitative imaging data.
Romix Bio
This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Biome Diagnostics
This company develops AI-powered microbiome diagnostic tools and cancer immunotherapy prediction tests for healthcare professionals, laboratories, and individual consumers.
Vortex Biotech
This company provides circulating tumour cell isolation systems for clinicians, researchers and pharmaceutical companies to support cancer diagnosis and patient monitoring.
